A 67-year-old man presented with a slow increase of prostate-specific antigen value after radical prostatectomy and postoperative radiotherapy for prostate cancer. The patient had received 3D conformal radiotherapy to a total dose of 66 Gy in 33 fractions of 2 Gy each on the prostatic bed. Three years later, a macroscopic local failure was diagnosed at the apical region. The patient could not receive androgenic deprivation therapy or other types of treatment owing to comorbid conditions. Thus, stereotactic body radiation therapy with helical image-guided tomotherapy was administered. The total dose was 30 Gy in 5 consecutive fractions of 6 Gy each to the site of the local failure. The treatment was preceded by a transperineal-guided injecti...
Up to 40% of patients who have received radiation for a pelvic malignancy will develop locoregional ...
Aims: Currently, when nodal pelvic oligorecurrent disease is detected, no standard treatment option ...
BackgroundSalvage re-irradiation in patients affected by radiorecurrent prostate cancer might be a v...
Prostate cancer recurrence in patients previously treated with radical prostatectomy and radiation t...
International audiencePurpose: To assess the efficacy and safety of salvage stereotactic body radiat...
Abstract Background Advances in imaging, biomaterials and precision radiotherapy provide new opportu...
A 47-year-old Japanese man was diagnosed with prostate cancer in February 1995 (Initial PSA 77.2 ng/...
tThe most popular therapeutic option in the management of radio-recurrent prostaticcarcinoma is repr...
BACKGROUND: and purpose: To assess the efficacy and safety of salvage stereotactic body radiotherapy...
The aim of this retrospective study was to assess the adverse effects and outcomes of salvage re-irr...
Copyright © 2015 Shogo Hosogoe et al.This is an open access article distributed under the Creative C...
Biochemical recurrences after radical prostatectomy (RP) can be managed with curative purpose throug...
BACKGROUND: Radiotherapy to the prostate bed is used to eradicate residual microscopic disease follo...
Abstract Background Currently, there is no standard option for local salvage treatment for local pro...
(1) Purpose: To investigate the role of68Ga-PSMA-11 PET/CT in guiding retreatment stereotactic body ...
Up to 40% of patients who have received radiation for a pelvic malignancy will develop locoregional ...
Aims: Currently, when nodal pelvic oligorecurrent disease is detected, no standard treatment option ...
BackgroundSalvage re-irradiation in patients affected by radiorecurrent prostate cancer might be a v...
Prostate cancer recurrence in patients previously treated with radical prostatectomy and radiation t...
International audiencePurpose: To assess the efficacy and safety of salvage stereotactic body radiat...
Abstract Background Advances in imaging, biomaterials and precision radiotherapy provide new opportu...
A 47-year-old Japanese man was diagnosed with prostate cancer in February 1995 (Initial PSA 77.2 ng/...
tThe most popular therapeutic option in the management of radio-recurrent prostaticcarcinoma is repr...
BACKGROUND: and purpose: To assess the efficacy and safety of salvage stereotactic body radiotherapy...
The aim of this retrospective study was to assess the adverse effects and outcomes of salvage re-irr...
Copyright © 2015 Shogo Hosogoe et al.This is an open access article distributed under the Creative C...
Biochemical recurrences after radical prostatectomy (RP) can be managed with curative purpose throug...
BACKGROUND: Radiotherapy to the prostate bed is used to eradicate residual microscopic disease follo...
Abstract Background Currently, there is no standard option for local salvage treatment for local pro...
(1) Purpose: To investigate the role of68Ga-PSMA-11 PET/CT in guiding retreatment stereotactic body ...
Up to 40% of patients who have received radiation for a pelvic malignancy will develop locoregional ...
Aims: Currently, when nodal pelvic oligorecurrent disease is detected, no standard treatment option ...
BackgroundSalvage re-irradiation in patients affected by radiorecurrent prostate cancer might be a v...